Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P734: Combining endoscopic and histological activity for predicting response to treatment

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Di Ruscio*1, A. Variola1, A. Geccherle1, G. Lunardi2, P. Castelli3, G. Zamboni3, R. Riddell4

1IRCCS Sacro Cuore Don Calabria, IBD Unit, Negrar, Italy, 2IRCCS Sacro Cuore Don Calabria, Division of Medical Oncology, Negrar, Italy, 3IRCCS Sacro Cuore Don Calabria, Department of Pathology, Negrar, Italy, 4Mount Sinai Hospital University of Toronto, Department of Pathology and Laboratory Medicine, Toronto, Canada

P735: Immunogenicity differences between anti-TNF drugs

ECCO '19 Copenhagen

Year: 2019
Authors:

R. M. Gómez Espín*1, I. Nicolás de Prado1, C. Iniesta Navalón2, L. Rentero Redondo2, M. Gil Candel2, J. J. Martínez Crespo1

1HGU Reina Sofía, Gastroenterology, Murcia, Spain, 2HGU Reina Sofía, Pharmacology, Murcia, Spain

P736: Characteristics of polymeric formula and mode of delivery of exclusive enteral nutrition have no effect on disease outcome and weight gain in children with Crohn’s disease

ECCO '19 Copenhagen

Year: 2019
Authors:

I. Hojsak*1, I. Trivic1, S. Sila1, K. Matic2, Z. Misak1, S. Kolacek1

1Children's Hospital Zagreb, Zagreb, Croatia, 2University of Zagreb, School of medicine, Zagreb, Croatia

P737: SPOSIB SB2: A Sicilian prospective observational study of patients with inflammatory bowel disease treated with infliximab Biosimilar SB2 (Flixabi®): interim analysis

ECCO '19 Copenhagen

Year: 2019
Authors:

F. S. Macaluso*1, M. Cappello2, E. Giuffrida2, W. Fries3, A. Centritto3, A. C. Privitera4, G. Inserra5, R. Vassallo6, A. Magnano7, E. Vinci7, S. Garufi8, M. Ventimiglia1, S. Renna1, R. Orlando1, G. Rizzuto1, M. Cottone1, A. Orlando1

1IBD Unit, "Villa Sofia-Cervello" Hospital, Palermo, Italy, 2Gastroenterology and Hepatology Unit, A.O.U. Policlinico ‘G. Giaccone’, Palermo, Italy, 3Inflammatory bowel disease Unit, A.O.U. Policlinico "G. Martino’, Messina, Italy, 4Inflammatory bowel disease Unit, A.O. "Cannizzaro’, Catania, Italy, 5Internal Medicine Unit, A.O.U. Policlinico ‘Vittorio Emanuele’, Catania, Italy, 6Gastroenterology and Endoscopy Unit, A.O. ‘Buccheri La Ferla Fatebenefratelli’, Palermo, Italy, 7Gastroenterology Unit, A.O.U. Policlinico ‘Vittorio Emanuele’, Catania, Italy, 8Gastroenterology Unit, A.O.O.R. ‘S. Elia- M. Raimondi’, Caltanissetta, Italy

P738: The budget impact of early dose optimisation with golimumab in ulcerative colitis in the UK

ECCO '19 Copenhagen

Year: 2019
Authors:

C. Black*1, A. Hirst2, A. Brandtmüller3, S. Kachroo1, A. Puenpatom3

1Merck & Co., Inc., Kenilworth, USA, 2ICON PLC, Dublin, Ireland, 3MSD, Budapest, Hungary

P739: The progression of inflammatory bowel disease throughout Latin America: a systematic review

ECCO '19 Copenhagen

Year: 2019
Authors:

P. Kotze*1, F. Underwood2, A. Damiao3, J. Ferraz2, R. Saad-Hossne4, M. Toro5, B. Iade6, F. Bosques-Padilla7, F. Teixeira8, F. Juliao-Baños9, D. Simian10, S. Ghosh11, R. Panaccione2, G. Kaplan2

1Catholic University of Paraná, IBD Outpatient Clinics, Colorectal Surgery Unit, Curitiba, Brazil, 2University of Calgary, Division of Gastroenterology and Hepatology, Calgary, Canada, 3University of Sao Paulo, Gastroenterology, Sao Paulo, Brazil, 4UNESP, Digestive Surgery, Botucatu, Brazil, 5Cuyo National University, Gastroenterology, Mendoza, Argentina, 6Hospital Maciel, Gastroenterology, Montevideo, Uruguay, 7Autonomous University of Nuevo Leon, Gastroenterology, Monterey, Mexico, 8Clinica Gastrosaude, IBD unit, Marilia, Brazil, 9Hospital Pablo Tobon Uribe, Gastroenterology, Medellin, Colombia, 10Clinica Las Condes, IBD unit, Santiago, Chile, 11NIHR Biomedical Research Centre, Institute of translational Medicine, Birmingham, UK

P740: Sexual quality of life in inflammatory bowel disease: a multi-centre, national-level study

ECCO '19 Copenhagen

Year: 2019
Authors:

J. Roseira*1, F. Magro2, S. Fernandes3, C. Simões3, F. Portela4, V. Ana Isabel5, M. Patita5, C. Leal6, P. Lago7, P. Caldeira8, T. Gago8, P. Currais9, A. Sampaio10, C. Dias2, H. Tavares de Sousa11, GEDII1

1Centro Hospitalar Universitário do Algarve, Gastroenterologia, Portimão, Portugal, 2Hospital de São João, Porto, Portugal, 3Hospital de Santa Maria, Lisboa, Portugal, 4Centro Hospitalar Universitário de Coimbra, Coimbra, Portugal, 5Hospital Garcia da Horta, Almada, Portugal, 6Centro Hospitalar de Leiria, Leiria, Portugal, 7Centro Hospitalar do Porto, Porto, Portugal, 8Centro Hospitalar Universitário do Algarve, Faro, Portugal, 9Instituto Português de Oncologia, Lisboa, Portugal, 10Associação Portuguesa da Doença Inflamatória do Intestino, Porto, Portugal, 11Centro Hospitalar Universitário do Algarve, Portimão, Portugal

P741: Fine-scale geographic distribution and ecological studies of Crohn’s disease in France (2007–2014)

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Genin*1, M. Fumery2, F. Occelli3, G. Savoye4, B. Pariente5, L. Dauchet6, C. Vignal7, M. Body-Malapel7, J. Giovannelli8, H. Sarter9, C. Gower-Rousseau8, G. Ficheur10

1University of Lille, EA2694 - Santé publique : épidémiologie et qualité des soins, Lille, France, 2Amiens University Hospital, Gastroenterology Unit, Amiens, France, 3University of Lille, EA 4483 - Impact de l’environnement chimique sur la santé humaine, Lille, France, 4Rouen University Hospital, Gastroenterology Unit, Rouen, France, 5Lille University Hospital, Gastroenterology Unit, Lille, France, 6Lille University hospital, INSERM, UMR1167, Lille, France, 7University of Lille, UMR 995, Lille, France, 8Lille University Hospital, UMR 995, Lille, France, 9Lille university Hospital, EA 2694 - Santé publique : épidémiologie et qualité des soins, Lille, France, 10Lille University Hospital, EA 2694 - Santé publique : épidémiologie et qualité des soins, Lille, France

P742: Iranian Registry of Crohn’s and Colitis (IRCC): first nation-wide IBD registry in Middle East, a study protocol

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Malekzadeh1, A. Sima2, S. Alatab2, A. Sadeghi2, N. Ebrahimi Daryani3, P. Adibi4, I. Maleki5, H. Vossoughinia6, H. Fakheri5, A. Yazdanbod7, S. A. Taghavi8, R. Aghazadeh9, M. H. Somi10, K. Zendehdel11,12, H. Vahedi1, R. Malekzadeh*1

1Digestive Disease Research Center, Digestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of, 2Digestive Disease Research Institute, Tehran, Iran, Islamic Republic of, 3Department of Gastroenterology, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of, 4Gastroenterology Section, Department of Internal Medicine, Isfahan University of Medical Sciences, Isfahan, Iran, Islamic Republic of, 5Gut and Liver Research Center, Mazandaran University of Medical Sciences, Sari, Iran, Islamic Republic of, 6Department of Gastroenterology and Hepatology, Ghaem Hospital, Medical Faculty, Mashhad University of Medical Sciences, Mashhad, Iran, Islamic Republic of, 7Department of Medicine, Ardabil University of Medical Science, Ardabil, Iran, Islamic Republic of, 8Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of, 9Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Islamic Republic of, 10Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran, Islamic Republic of, 11Deputy of Research, Ministry of Health and Medical Education, Tehran, Iran, Islamic Republic of, 12Cancer Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of

P743: Bone mineral disease is insufficiently evaluated in patients with inflammatory bowel disease at risk of metabolic bone disease: results from a Danish population-based inception cohort study

ECCO '19 Copenhagen

Year: 2019
Authors:

B. Lo*1, I. Vind1, M. K. Vester-Andersen1,2, J. P. Holm3, F. Bendtsen1, J. Burisch1

1Copenhagen University Hospital Hvidovre, The Gastro Unit, Hvidovre, Denmark, 2Zealand University Hospital, Medical Department, Koege, Denmark, 3Copenhagen University Hospital Herlev, Deparment of Endocrinology, Herlev, Denmark

P744: A significant decline in surgical resections during childhood with increased prevalence of anti-TNF therapy in patients with paediatric inflammatory bowel disease

ECCO '19 Copenhagen

Year: 2019
Authors:

J. J. Ashton*1,2, F. Borca3, E. Mossotto2,3, T. Coelho1, A. Batra1, N. Afzal1, H. Phan3, M. Stanton1, S. Ennis2, R. M. Beattie1

1Southampton Children's Hospital, Department of Paediatric Surgery, Southampton, UK, 2University Hospital Southampton, Department of Human Genetics and Genomic Medicine, Southampton, UK, 3University Hospital Southampton, NIHR Southampton Biomedical Research Centre, Southampton, UK

P745: Incidence of indeterminate colitis in the EPIMAD registry decreases over the period 1988–2014

ECCO '19 Copenhagen

Year: 2019
Authors:

P. Mayer*1, H. Sarter2,3, M. Fumery2,4, G. Savoye5, A. Leroyer3, L. Dauchet3, C. Gower-Rousseau2,3, B. Pariente1

1Lille University Hospital, Gastroenterology Unit, Hôpital Huriez, Lille, France, 2Lille University, CHRU de Lille, Lille Inflammation Research International Centre LIRIC - UMR 995 Inserm, Lille, France, 3Lille University and Hospital, Public Health, Epidemiology and Economic Health, Register Epimad, Lille, France, 4CHU Amiens Sud, l, Amiens University Hospital, Gastroenterology Unit, Epimad Registry, Amiens, France, 5Hôpital Charles Nicolle, Rouen University Hospital, Gastroenterology Unit, Epimad Registry, Rouen, France

P746: Living with ulcerative colitis in Germany: quantifying the socioeconomic impact of moderate to severe ulcerative colitis

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Dignass*1, J. Waller2, J. C. Cappelleri3, L. Salese4, A. Kisser5, L. Dietz5, M. DiBonaventura6, R. Wood2, D. Bargo6

1Agaplesion Markus Hospital, Frankfurt/Main, Germany, 2Adelphi Real World, Bollington, UK, 3Pfizer Inc., Groton, CT, USA, 4Pfizer Inc., Collegeville, PA, USA, 5Pfizer Germany GmbH, Berlin, Germany, 6Pfizer Inc., New York, NY, USA

P747: A sharp increase of using biologics for IBD in Israel: a population- based report from the epiIIRN database

ECCO '19 Copenhagen

Year: 2019
Authors:

Y. Chowers1, N. Asayag*2, N. Dan3, G. Focht3, R. Balicer4, E. Zittan4, E. Matz5, I. Brufman4, B. Feldman4, A. Cahan6, N. Lederman7, I. Dotan4, E. Israeli8, D. Turner3

1Department of Gastroenterology, Rambam Health Care Campus, Haifa, Israel; Bruce Rappaport School of Medicine, Technion Israel Institute of Technology, Haifa, Israel., Haifa, Israel, 2Shaare Zedek Medical Center, The Juliet Keidan Institute of Paediatric Gastroenterology and Nutrition, Jerusalem, Israel, 3Shaare Zedek Medical Center, Jerusalem, Jerusalem, Israel, 4Clalit Research Institute, Chief’s Office, Clalit Health Services, Tel Aviv, Israel, Tel Aviv, Israel, 56 Leumit Health Services, Tel Aviv, Israel, Tel Aviv, Israel, 6Maccabi Healthcare Services, Tel Aviv, Israel, Tel Aviv, Israel, 7Meuhedet Health Services, Tel Aviv, Israel, Tel Aviv, Israel, 8Institute of Gastroenterology and Liver Diseases, Hadassah Medical Center, Hebrew University, Jerusalem, Israel, Jerusalem, Israel

P748: Retrospective study on incidence rates of NAFLD and advanced liver fibrosis in Crohn's disease and ulcerative colitis

ECCO '19 Copenhagen

Year: 2019
Authors:

V. Domislovic*1, I. Knezevic Stromar1, M. Premuzic1, D. Vranesic Bender2,3, M. Matasin4, A. Milinkovic4, I. Mikolasevic5,6, Z. Krznaric1,2,4

1Clinical Hospital Centre Zagreb, Department of Gastroenterology and Hepatology, Zagreb, Croatia, 2Unit of Clinical Nutrition, University Hospital Zagreb, Zagreb, Croatia, 3Faculty of Food Technology and Biotechnology, University of Zagreb, Zagreb, Croatia, 4University of Zagreb, School of Medicine, Zagreb, Croatia, 5University Hospital Centre Rijeka, Department of gastroenterology and hepatology, Rijeka, Croatia, 6University of Rijeka, School of Medicine, Rijeka, Croatia

P749: Early environmental and lifestyle factors are associated with developing inflammatory bowel disease

ECCO '19 Copenhagen

Year: 2019
Authors:

K. van der Sloot*1,2, R. Weersma1, B. Alizadeh2, G. Dijkstra1

1University Medical Center Groningen/University of Groningen, Gastroenterology and Hepatology, Groningen, The Netherlands, 2University Medical Center Groningen/University of Groningen, Epidemiology, Groningen, The Netherlands

P750: Association between the use of antihypertensive agents and disease severity in patients with inflammatory bowel disease

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Mantaka*1, E. Tsoukali2, M. Fragaki3, K. Karmiris3, N. Viazis2, G. Mantzaris2, I. Koutroubakis1

1University Hospital of Heraklion, Department of Gastroenterology, Heraklion, Greece, 2Evangelismos General Hospital, Department of Gastroenterology, Athens, Greece, 3Venizeleio General Hospital, Department of Gastroenterology, Heraklion, Greece

P751: Perianal lesions in Crohn's disease: analysis of Epimad registry from 2007 to 2012

ECCO '19 Copenhagen

Year: 2019
Authors:

P. Wils*1, A. Leroyer2, M. Fumery3, A. Fernandez Nistal4, D. Bojic4, R. D′Ambrosio4, H. Sarter2, G. Savoye5, C. Gower-Rousseau2, B. Pariente6

1Claude Huriez Hospital, Gastroenterology Unit, Lille, France, 2University of Lille, Epidemiology Unit, EPIMAD registry, Lille, France, 3Amiens Hospital, Amiens, France, 4Takeda, Paris, France, 5Rouen Hospital, Rouen, France, 6Claude Huriez Hospital, University of Lille, Gastroenterology unit, Lille, France

P752: Increased risk of hip fracture in patients with inflammatory bowel disease: a national registry-based nested case–control study

ECCO '19 Copenhagen

Year: 2019
Authors:

J. Bartko*1, B. Reichardt2, R. Kocijan1, K. Klaushofer1, J. Zwerina1, M. Behanova1

1Ludwig Boltzmann-Institute of Osteology at the Hanusch Hospital of WGKK and Trauma Centre Meidling of AUVA, 1st Medical Department, Hanusch Hospital, Vienna, Austria, 2Sickness Fund Burgenland, Burgenländische Gebietskrankenkasse, Eisenstadt, Austria

P753: Increased risk of ulcerative colitis in patients with periodontitis: a nationwide population-based study

ECCO '19 Copenhagen

Year: 2019
Authors:

J. S. Kim*1, E. A. Kang1, K. Han2, J. Kim3, J. P. Im1, J. Chun1, H. Soh1, S. Park1

1Seoul National University College of Medicine, Department of Internal Medicine, Seoul, South Korea, 2the Catholic University of Korea, Seoul St. Mary's Hospital, Department of Medical Statistics, Seoul, South Korea, 3Seoul National University College of Medicine, SMG-SNU Boramae Medical Center, Department of Internal Medicine, Seoul, South Korea